UMC Utrecht researchers compared three different pneumonia treatment strategies in seven hospitals over a 90-day period. The treatments studied included a beta-lactam antibiotic, which is a traditional medicine similar to penicillin; a beta-lactam antibiotic paired with a macrolide antibiotic; and a relatively new fluoroquinolone antibiotic.
The mortality rate for all three treatment strategies was roughly 10 percent, indicating relatively no difference in their effectiveness.
The beta-lactam antibiotics, however, were less likely to cause antibiotic resistance than the other two studied strategies, according to the researchers.
More articles on antibiotics:
White House to release plan to reduce antibiotic resistance
Chlorine used in wastewater treatment may boost antibiotic resistance, study finds
Huggins Hospital partners with local farm for hormone, antibiotic-free beef
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
